key: cord-0948199-kscgsqux authors: Saseedharan, Sanjith; Karanam, Roopa; Kadam, Vaijayanti; Shirsekar, Suvarna title: Smart secretion management to protect nurses from COVID19 and other infectious diseases date: 2021-01-11 journal: Nurs Crit Care DOI: 10.1111/nicc.12586 sha: dfe4a3d14169aad747b0c108172fbabb2d346808 doc_id: 948199 cord_uid: kscgsqux BACKGROUND: COVID‐19 has been linked to over 40 million infections and 1.1 million deaths in 210 countries as of October 19, 2020. This highly contagious communicable disease has put not only infected individuals but other patients and frontline workers like nurses at risk in hospitals, especially in Intensive Care units (ICUs). There is a need for minimizing patient contact, improving hand hygiene practices, and optimizing healthcare provider time, especially nurses. Globally it is estimated that nearly a million health care providers have been infected with COVID‐19 as of the end of October 2020. METHODS: This retrospective service evaluation documents the experience of health care providers in a COVID‐19 ICU in India that was used to implement new protocols for secretion management and oral hygiene. Patient chart information and staff feedback were utilized. INTERVENTION: This pilot study captures the practical benefits of using VAPCare, an automated, closed‐loop system for oral secretion removal. RESULTS: Six patients were included in this small‐scale study; three patients following the current standard of care for suctioning and oral hygiene and three receiving the new VAPCare and Lumen device protocol. With the new device protocol, the number of infected secretion interactions by a nurse was 50% lower, and nursing time spent on oral hygiene and secretion management 70% less than seen with the current standard of care. The number of disposable gloves used with VAPCare and Lumen was reduced by over 50%. All 10 nurses and six doctors gave positive feedback on device usage. The department recommended updating protocols to prioritize the use of the new secretion management system for patients with COVID19 and other highly contagious conditions. CONCLUSION: The findings are an early indication that using VAPCare for patients could help protect infected patients, other ICU patients, and health care workers. novel coronavirus and has been linked to over 40 million infections, and 1.1 million deaths in 210 countries as of October 19, 2020. 3 In India alone by July 2020, over 1000 health care workers (doctors and nurses) have tested positive for COVID-19. 4, 5 Data from the United States of America indicate that as of September 2020, over 570 000 health care providers were infected in North America. 6 Ventilator-Associated Pneumonia (VAP) continues to be a leading cause of morbidity and mortality in intubated patients. 7 The primary pathogenesis is microaspiration of secretions from oropharynx into the distal bronchi. [8] [9] [10] Challenges in dealing with ventilated patients include managing the need for heavy sedation to prevent patients biting staff or the Endotracheal tube (ETT), the collection of fomites from use of the same suction line and tube over time, and the generation of infectious aerosols from turbid suctioning in normal pressure environments. 11, 12 Transmission to other patients and nurses has been a significant feature globally (up to 41% of cases) of both outbreaks of Severe acute respiratory syndrome (SARS), Middle East Respiratory Syndrome (MERS), and now COVID-19. 13, 14 The highest numbers of nurse and doctor infections (as a proportion of all health care workers) have been recorded in middle-and low-income countries compared with higher-income ones. 13 However, from the data, nurses and other frontline health care providers are disproportionately affected by infectious diseases when there is a massive outbreak. 13, 14 The long working hours, lack of appropriate Personal Protective Equipment (PPE) availability, high infection contact, and suboptimal cleanliness have been linked to the increased spread of any communicable disease like COVID-19. 15, 16 This risk is further magnified in resourceconstrained settings making cluster care challenging. Suctioning with adequate oral hygiene protocols remains crucial for intubated patients. Such protocols include secretion management in the oral, oropharyngeal, and subglottic regions of a patient's respiratory tract; along with teeth brushing and antimicrobial rinses. 17 This pilot study considered the performance and safety aspects of an automated device, VAPCare, along with a disposable product (Lumen) in delivering secretion and oral hygiene management. The nursing time spent, patient contact duration, secretion collection, and personal protective equipment (PPE) usage were observed in a small number of patients where the device was used and in patients where manual suction and oral hygiene protocols were followed. The study was completed at a tertiary care ICU of a National Accreditation Board for Hospitals (NABH) accredited Hospital in Mumbai, India. This paper aims to present the initial evaluation of a new medical device to reduce nursing time spent and contact duration with infectious secretions of COVID-19 patients. The pilot study hospital is an accredited tertiary care centre that follows established best practices for patient hygiene, secretion What is known about this topic • Minimising direct patient contact for nurses caring for infectious disease patients helps reduce infection spread. • Typical oral hygiene and secretion management cause the generation of aerosols multiple times a day increasing transmission risk from droplets. • Personal protective equipment and nursing time are often scarce during an outbreak. • Nurses becoming infected puts vulnerable populations at further risk and harms the health care system. • This paper leads to an updated secretion management and oral hygiene protocol to reduce viral load exposure. This pilot study is a retrospective chart review that serves as a new service evaluation pilot study. The primary aim of this study was to assess performance to update hospital protocols. The ongoing pandemic made time the driving factor for completion; thus, a smaller sample size was used. The chart review was performed between the first of April 2020 and the 28th of April 2020, on adult, mechanically ventilated COVID-19 patients who did not have any other communicable disease. All nursing and medical staff had been trained on VAPCare during installation by the manufacturer between February and March 2020. Patients included in this study were intubated following standard protocols using an ETT with a subglottic port in the hospital. Transfer patients with trauma or who were already intubated were not included in this study. Only the first 24 hours on the device or manual suctioning was considered for analysis. These data were gathered by reviewing physi- Device performance was assessed in person by nursing staff (10) and treating doctors (6) . The investigators performed a subjective one on one feedback-gathering exercise with the ICU medical team. All the staff had been part of both manual and VAPCare protocols at some point during the study. All 16 health care providers used the term "useful" and "safer" in their feedback and either "easy" or "userfriendly" as well with regards to VAPCare. As seen in Table 1 There are limitations to this small study. There was no separation of staff between the two groups, so it is difficult to make firm conclusions on the additional safety of the product. The highly contagious nature of the virus itself along with the multiple patient contact points would make it impossible to link any staff testing positive for COVID- None of the investigators/authors has any financial interest in the company or personal relationships with the organization that could bias the study. This paper is a self-published study and has received no financial support from any external organization. There was no external funding for the research presented. The study was conducted per the Helsinki Declaration. This study was a retrospective case study for a service evaluation, no formal IERB approval or registration was required. No animals were used in the study. A novel coronavirus from patients with pneumonia in China Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia Coronavirus cases staffers, including two doctors of Max hospital, test positive for COVID-19. India Today COVID-19 has infected some 570,000 health workers and killed 2,500 in the Americas, PAHO Director says Clinical and economic consequences of ventilator-associated pneumonia: a systematic review Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare associated pneumonia The pathogenesis of ventilator-associated pneumonia: I. Mechanisms of bacterial transcolonization and airway inoculation Hospital-acquired pneumonia: etiologic considerations Guidelines for Preventing Health-Care-Associated Pneumonia, 2003: Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee Benefits of automated intermittent subglottic secretion drainage Clinical characteristics of 138 hospitalised patients with 2019 novel coronavirus-infected pneumonia in Wuhan Critically ill healthcare workers with the Middle East respiratory syndrome (MERS): a multicenter study Risk factors of healthcare workers with corona virus disease 2019: a retrospective cohort study in a designated hospital of Wuhan in China COVID-19: a novel coronavirus and a novel challenge for critical care British Association of Critical Care Nurses: evidence-based consensus paper for oral care within adult critical care units Smart secretion management to protect nurses from COVID19 and other infectious diseases